Genus says results in line with last year

Animal genetics company Genus said results for the first nine months are in line with last year's record performance.

Animal genetics company Genus said results for the first nine months are in line with last year's record performance.

The group's revenues were flat and pre-tax profits were 1.0% lower in constant currency for the period, despite the impact of higher feed costs and investments.

Market conditions for the company's bovine and porcine customers continued to be challenging, with pressure on profitability from input and output prices.

Genus expects to end the year with low single-digit percentage growth in profit before tax in constant currency.

In its Pig Improvement Company (PIC), the firm achieved double-digit profit growth in Latin America driven by a higher mix of royalty business.

However, performance in North America was affected by lower volumes of animal shipments to customers whose expansion plans were halted to low industry profitability.

In Europe, PIC was broadly consistent with the prior year and is making continued progress with the restructuring of this business.

Profits in Genus PIC for the first nine months were up 4.0% in constant currency.

The company's ABS Global business, an artificial insemination company that sells frozen bovine semen from different breeds of cattle, experienced a decline in volumes due to high feed costs and low milk prices in key markets including the US and Latin America.

ABS profits for the first nine months were 6.0% lower in constant currency.

Despite tough markets in Europe and the US, the company recorded growth in its Asia porcine business as it doubled volumes and profits in the period. China and Philippines wielded particularly robust results.

Research and development spending grew as expected by 13% in constant currency as investment continued and ongoing higher feed costs were incurred in the porcine genetic nucleus farms.

Net debt at the end of March was at a similar level to the end of December.

Genus said it plans to continue investing in proprietary data and indices across the dairy, beef and porcine markets.

RD

Recommended

Broker safety – your questions answered
Investment strategy

Broker safety – your questions answered

Cris Sholto Heaton answers more of your questions about the safety of stockbroker accounts
25 Mar 2020
How demographics affects stock valuations
Investment strategy

How demographics affects stock valuations

New research suggests that stock and bond valuations are driven by the age of the population – at least in the US.
24 Feb 2020
Do you own shares in Sirius Minerals? Here’s what you need to do now
Stocks and shares

Do you own shares in Sirius Minerals? Here’s what you need to do now

Mining giant Anglo American has proposed a cash takeover of Yorkshire-based minnow Sirius Minerals. Unhappy shareholders must decide whether to accept…
20 Feb 2020
Why investors should be “cautiously bullish” for 2020
Stockmarkets

Why investors should be “cautiously bullish” for 2020

Analysts have been out in force making rosy predictions for stockmarkets in 2020, but while there is certainly a case for optimism, investors should r…
17 Jan 2020

Most Popular

Will a second wave of Covid lead to another stockmarket crash?
Stockmarkets

Will a second wave of Covid lead to another stockmarket crash?

Can we expect to see another lockdown like in March, and what will that mean for your money? John Stepek explains.
18 Sep 2020
Here’s why you really should own at least some bitcoin
Bitcoin

Here’s why you really should own at least some bitcoin

While bitcoin is having a quiet year – at least in relative terms – its potential to become the default cash system for the internet is undiminished, …
16 Sep 2020
IAG's share price is ready for take-off - here's how to play it
Trading

IAG's share price is ready for take-off - here's how to play it

The owner of British Airways has had a turbulent year, but is now worth a punt. Matthew Partridge explains the best way to play it.
8 Sep 2020